Elevance Health, Inc. (ELV) KPIs and segments
Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Elevance Health · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của Elevance Health: 82 chỉ số vận hành, trong đó có Total Medical Membership, Specialty Membership — Vision Members và Specialty Membership — Dental Members, lấy từ 381 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carelon Services2 | |||||||||||||
Service fees($M) | 206 | 207 | 203 | 180 | 191 | 232 | 223 | 196 | 201 | 196 | 197 | 186 | |
Product revenue($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
CarelonRx2 | |||||||||||||
Product revenue($M) | 6,454 | 6,264 | 6,225 | 6,460 | 6,159 | 6,042 | 5,809 | 6,714 | 5,887 | 5,530 | 4,499 | 5,394 | |
Service fees($M) | 1 | 3 | 4 | 2 | 4 | 4 | 3 | 1 | 2 | 1 | 1 | 2 | |
Corporate & Other2 | |||||||||||||
Service fees($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10 | 17 | 4 | 1 | ||
Product revenue($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Health Benefits2 | |||||||||||||
Service fees($M) | 2,075 | 2,073 | 2,038 | 1,979 | 1,942 | 1,872 | 1,843 | 1,838 | 1,830 | 2,063 | 1,876 | 1,733 | |
Product revenue($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Product revenue($M) | 6,454 | 6,264 | 6,225 | 6,460 | 6,159 | 6,042 | 5,809 | 6,714 | 5,887 | 5,530 | 4,499 | 5,394 | |
Service fees($M) | 2,282 | 2,283 | 2,245 | 2,161 | 2,137 | 2,108 | 2,069 | 2,030 | 2,023 | 2,277 | 2,078 | 1,922 | |
CarelonRx($M) | 616 | 582 | 582 | 724 | 556 | 536 | 602 | 533 | 619 | 497 | 523 | 490 | |
Health Benefits($M) | 436 | 896 | 2,157 | -220 | 601 | 1,560 | 2,217 | 207 | 1,604 | 2,145 | 2,287 | 767 | |
Carelon Services($M) | 292 | 366 | 470 | -150 | 219 | 400 | 491 | 35 | 184 | 208 | 290 | 102 | |
Corporate & Other($M) | -75 | -81 | -1,123 | -45 | -81 | -71 | -140 | -102 | -999 | -85 | -84 | -75 | |
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)1 | |||||||||||||
Total Medical Membership5 | 44,882.00 | 44,949.00 | 45,418.00 | 45,232.00 | 45,369.00 | 45,621.00 | 45,833.00 | 45,734.00 | 45,760.00 | 45,776.00 | 46,049.00 | 46,829.00 | |
Commercial Fee-Based Medical Membership (Self-Funded & BlueCard®)2 | 27,605.00 | 27,513.00 | 27,749.00 | 27,092.00 | 27,002.00 | 27,154.00 | 27,130.00 | 27,199.00 | 27,266.00 | 27,234.00 | 27,257.00 | 26,933.00 | |
Employer Group Fee-Based Medical Membership (Self-Funded / ASO) | 21,009.00 | 20,931.00 | 21,170.00 | 20,583.00 | 20,608.00 | 20,584.00 | 20,522.00 | 20,569.00 | 20,589.00 | 20,542.00 | 20,622.00 | 20,227.00 | |
BlueCard® Host Medical Membership | 6,596.00 | 6,582.00 | 6,579.00 | 6,509.00 | 6,394.00 | 6,570.00 | 6,608.00 | 6,630.00 | 6,677.00 | 6,692.00 | 6,635.00 | 6,706.00 | |
Commercial Risk-Based Medical Membership (Fully-Insured)2 | 4,714.00 | 4,734.00 | 4,863.00 | 4,924.00 | 4,970.00 | 4,963.00 | 5,061.00 | 5,000.00 | 4,971.00 | 4,929.00 | 4,894.00 | 4,781.00 | |
Employer Group Risk-Based Medical Membership | 3,366.00 | 3,417.00 | 3,439.00 | 3,617.00 | 3,616.00 | 3,615.00 | 3,638.00 | 3,713.00 | 3,672.00 | 3,648.00 | 3,648.00 | 3,756.00 | |
Individual Medical Membership (ACA Marketplace & Off-Exchange) | 1,348.00 | 1,317.00 | 1,424.00 | 1,307.00 | 1,354.00 | 1,348.00 | 1,423.00 | 1,287.00 | 1,299.00 | 1,281.00 | 1,246.00 | 1,025.00 | |
Medicaid Managed Care Medical Membership (TANF, Expansion, ABD & LTSS) | 8,220.00 | 8,358.00 | 8,456.00 | 8,500.00 | 8,645.00 | 8,733.00 | 8,862.00 | 8,917.00 | 8,926.00 | 9,028.00 | 9,327.00 | 10,503.00 | |
Total Medicare Medical Membership2 | 2,796.00 | 2,790.00 | 2,787.00 | 3,112.00 | 3,122.00 | 3,129.00 | 3,131.00 | 2,957.00 | 2,941.00 | 2,925.00 | 2,913.00 | 2,970.00 | |
Medicare Advantage Membership (Part C Individual & Group) | 1,898.00 | 1,897.00 | 1,899.00 | 2,230.00 | 2,245.00 | 2,255.00 | 2,255.00 | 2,066.00 | 2,047.00 | 2,031.00 | 2,017.00 | 2,047.00 | |
Medicare Supplement (Medigap) Membership | 898.00 | 893.00 | 888.00 | 882.00 | 877.00 | 874.00 | 876.00 | 891.00 | 894.00 | 894.00 | 896.00 | 923.00 | |
Federal Employee Program (FEP® / FEHB) Medical Membership | 1,547.00 | 1,554.00 | 1,563.00 | 1,604.00 | 1,630.00 | 1,642.00 | 1,649.00 | 1,661.00 | 1,656.00 | 1,660.00 | 1,658.00 | 1,642.00 | |
Specialty Membership — Vision Members | 11,895.00 | 11,912.00 | 11,975.00 | 10,842.00 | 10,770.00 | 10,817.00 | 10,419.00 | 10,382.00 | 10,275.00 | 10,251.00 | 9,944.00 | ||
Specialty Membership — Dental Members1 | 7,445.00 | 7,480.00 | 7,556.00 | 7,364.00 | 7,346.00 | 7,394.00 | 7,282.00 | 7,021.00 | 7,008.00 | 6,970.00 | 6,820.00 | ||
Specialty Membership — Dental Administration Members (Network / Third-Party) | 1,932.00 | 1,940.00 | 1,944.00 | 1,957.00 | 1,961.00 | 1,966.00 | 1,887.00 | 1,878.00 | 1,851.00 | 1,841.00 | 1,729.00 | ||
Specialty Membership — Medicare Part D Standalone Members | 79.00 | 78.00 | 77.00 | 217.00 | 219.00 | 221.00 | 256.00 | 258.00 | 260.00 | 262.00 | 260.00 | ||
CarelonRx — Quarterly Adjusted Prescription Scripts(M) | 82.6 | 80.9 | 80.3 | 88.5 | 85 | 83.3 | 83.9 | 82.9 | 80.2 | 78.2 | 77 | 78 | |
Carelon Services — Consumers Served(M) | 91 | 92.4 | 92.9 | 91.8 | 97.6 | 97.3 | 99.5 | 101 | 101 | 102 | 103 | 103 | |
Total Consolidated Operating Revenue (Reportable Segments)($M)4 | 50,440 | 49,826 | 49,494 | 49,311 | 50,087 | 49,421 | 48,765 | 44,989 | 44,719 | 43,223 | 42,273 | 42,454 | |
Health Benefits Segment — Total Operating Revenue($M)8 | 43,357 | 42,720 | 42,490 | 41,835 | 42,246 | 41,582 | 41,431 | 37,580 | 38,278 | 37,159 | 37,258 | 36,547 | |
Health Benefits Operating Revenue — Commercial (Group & Individual)($M)1 | 13,343 | 13,561 | 13,238 | 12,747 | 12,849 | 12,453 | 12,352 | 11,851 | 11,639 | ||||
of which: Individual (ACA) Health Benefits Operating Revenue($M) | 2,514 | 2,720 | 2,540 | 2,248 | 2,358 | 2,328 | 2,361 | 2,117 | 2,082 | ||||
Health Benefits Operating Revenue — Medicaid($M) | 14,979 | 14,444 | 14,280 | 14,500 | 14,166 | 13,911 | 14,043 | 12,755 | 13,063 | ||||
Health Benefits Operating Revenue — Medicare($M) | 11,229 | 10,962 | 10,991 | 10,762 | 11,138 | 11,446 | 11,406 | 9,054 | 9,385 | ||||
Health Benefits Operating Revenue — Federal Employee Program (FEP®)($M) | 3,806 | 3,753 | 3,981 | 3,826 | 4,093 | 3,772 | 3,630 | 3,920 | 4,191 | ||||
Health Benefits — Premiums Revenue (Note 13 / Note 20)($M) | 41,282 | 40,647 | 40,452 | 39,856 | 40,304 | 39,710 | 39,588 | 35,742 | 36,448 | 35,096 | 35,382 | 34,814 | |
Health Benefits — Administrative Service Fees Revenue (Note 13 / Note 20)($M) | 2,075 | 2,073 | 2,038 | 1,979 | 1,942 | 1,872 | 1,843 | 1,838 | 1,830 | 2,063 | 1,876 | 1,733 | |
Health Benefits — Segment Benefit Expense (ASU 2023-07)($M) | 37,625 | 36,739 | 35,453 | 37,164 | 36,845 | 35,487 | 34,393 | 33,042 | 32,724 | 30,437 | 30,500 | ||
Health Benefits — Segment Operating Expense (ASU 2023-07)($M) | 5,296 | 5,085 | 4,880 | 4,891 | 4,800 | 4,535 | 4,821 | 4,331 | 3,950 | 4,577 | 4,471 | ||
Total Carelon (CarelonRx + Carelon Services) — Operating Revenue($M)7 | 19,307 | 19,225 | 17,965 | 18,659 | 18,321 | 18,084 | 16,652 | 14,746 | 13,781 | 13,319 | 12,076 | 12,401 | |
CarelonRx Segment — Total Operating Revenue($M)4 | 11,599 | 11,250 | 10,600 | 11,644 | 10,997 | 10,643 | 10,116 | 9,977 | 9,143 | 8,774 | 8,067 | 8,827 | |
CarelonRx — Unaffiliated (External Third-Party) Operating Revenue($M) | 6,455 | 6,267 | 6,229 | 6,462 | 6,163 | 6,046 | 5,812 | 6,715 | 5,889 | 5,531 | 4,500 | 5,396 | |
CarelonRx — Affiliated (Intersegment) Operating Revenue($M) | 5,144 | 4,983 | 4,371 | 5,182 | 4,834 | 4,597 | 4,304 | 3,262 | 3,254 | 3,243 | 3,567 | 3,431 | |
CarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07)($M) | 10,779 | 10,473 | 9,830 | 10,700 | 10,209 | 9,884 | 9,284 | 9,229 | 8,336 | 8,040 | 7,373 | ||
CarelonRx — Segment Operating Expense (ASU 2023-07)($M) | 204 | 195 | 188 | 220 | 232 | 223 | 230 | 215 | 188 | 237 | 171 | ||
Carelon Services Segment — Total Operating Revenue($M)6 | 7,708 | 7,975 | 7,365 | 7,015 | 7,324 | 7,441 | 6,536 | 4,769 | 4,638 | 4,545 | 4,009 | 3,574 | |
Carelon Services — Unaffiliated (External Third-Party) Operating Revenue($M) | 875 | 1,040 | 982 | 1,370 | 1,953 | 2,095 | 1,723 | 944 | 881 | 990 | 605 | 604 | |
Carelon Services — Affiliated (Intersegment) Operating Revenue($M) | 6,833 | 6,935 | 6,383 | 5,645 | 5,371 | 5,346 | 4,813 | 3,825 | 3,757 | 3,555 | 3,404 | 2,970 | |
Carelon Services — Premiums Revenue (Risk-Based Capitation)($M) | 669 | 833 | 779 | 1,190 | 1,762 | 1,863 | 1,500 | 748 | 680 | 794 | 408 | 418 | |
Carelon Services — Service Fees Revenue($M) | 206 | 207 | 203 | 180 | 191 | 232 | 223 | 196 | 201 | 196 | 197 | 186 | |
Carelon Services — Segment Benefit Expense (incl. Intersegment, ASU 2023-07)($M) | 6,521 | 6,743 | 6,085 | 6,325 | 6,349 | 6,290 | 5,319 | 3,979 | 3,767 | 3,632 | 3,010 | ||
Carelon Services — Segment Operating Expense (ASU 2023-07)($M) | 895 | 866 | 810 | 840 | 756 | 751 | 726 | 755 | 687 | 705 | 709 | ||
Total Carelon — Unaffiliated (External Third-Party) Operating Revenue($M) | 7,330 | 7,307 | 7,211 | 7,832 | 8,116 | 8,141 | 7,535 | 7,659 | 6,770 | 6,521 | 5,105 | 6,000 | |
Total Carelon — Affiliated (Intersegment) Operating Revenue($M) | 11,977 | 11,918 | 10,754 | 10,827 | 10,205 | 9,943 | 9,117 | 7,087 | 7,011 | 6,798 | 6,971 | 6,401 | |
Total Carelon — Segment Benefit Expense (ASU 2023-07)($M) | 6,521 | 6,743 | 6,085 | 6,325 | 6,349 | 6,290 | 5,319 | 3,979 | 3,767 | 3,632 | 3,010 | ||
Total Carelon — Cost of Products Sold (ASU 2023-07)($M) | 10,779 | 10,473 | 9,830 | 10,700 | 10,209 | 9,884 | 9,284 | 9,229 | 8,336 | 8,040 | 7,373 | ||
Total Carelon — Segment Operating Expense (ASU 2023-07)($M) | 1,099 | 1,061 | 998 | 1,060 | 988 | 974 | 956 | 970 | 875 | 942 | 880 | ||
Corporate & Other — Operating Revenue($M) | 6 | 6 | 4 | -83 | 149 | 232 | 165 | -14 | 74 | 122 | 127 | 181 | |
Intersegment Operating Revenue Eliminations($M) | -12,230 | -12,125 | -10,965 | -11,100 | -10,629 | -10,477 | -9,483 | -7,323 | -7,414 | -7,377 | -7,188 | -6,675 | |
Total Reportable Segments — GAAP Operating Gain($M)4 | 1,269 | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 | 1,408 | 2,765 | 3,016 | 1,284 | |
Total Reportable Segments — Adjusted Operating Gain (Non-GAAP)($M) | 1,337 | 1,818 | 3,204 | 375 | 1,344 | 2,488 | 3,255 | 841 | 2,459 | 2,901 | 3,126 | 1,358 | |
Non-GAAP Adjustment Items to Reportable Segments Operating Gain($M) | 68 | 55 | 1,118 | 66 | 49 | 63 | 85 | 168 | 1,051 | 136 | 110 | 74 | |
Health Benefits Segment — GAAP Operating Gain (Loss)($M)1 | 436 | 896 | 2,157 | -220 | 601 | 1,560 | 2,217 | 207 | 1,604 | 2,145 | 2,287 | 767 | |
Health Benefits — GAAP Operating Margin (%)(%) | 1.0% | 2.1% | 5.1% | -0.5% | 1.4% | 3.8% | 5.4% | 0.6% | 4.2% | 5.8% | 6.1% | 2.1% | |
Total Carelon — GAAP Operating Gain($M)3 | 908 | 948 | 1,052 | 574 | 775 | 936 | 1,093 | 568 | 803 | 705 | 813 | 592 | |
CarelonRx Segment — GAAP Operating Gain($M)1 | 616 | 582 | 582 | 724 | 556 | 536 | 602 | 533 | 619 | 497 | 523 | 490 | |
CarelonRx — GAAP Operating Margin (%)(%) | 5.3% | 5.2% | 5.5% | 6.2% | 5.1% | 5.0% | 6.0% | 5.3% | 6.8% | 5.7% | 6.5% | 5.6% | |
Carelon Services Segment — GAAP Operating Gain (Loss)($M)1 | 292 | 366 | 470 | -150 | 219 | 400 | 491 | 35 | 184 | 208 | 290 | 102 | |
Carelon Services — GAAP Operating Margin (%)(%) | 3.8% | 4.6% | 6.4% | -2.1% | 3.0% | 5.4% | 7.5% | 0.7% | 4.0% | 4.6% | 7.2% | 2.9% | |
Total Carelon — GAAP Operating Margin (%)(%) | 4.7% | 4.9% | 5.9% | 3.1% | 4.2% | 5.2% | 6.6% | 3.9% | 5.8% | 5.3% | 6.7% | 4.8% | |
Benefit Expense Ratio (BER / Medical Loss Ratio — % of Premiums)(%) | 90.6% | 89.7% | 86.8% | 93.5% | 91.3% | 88.9% | 86.4% | 92.4% | 89.5% | 86.3% | 85.6% | 89.2% | |
Days in Claims Payable (DCP)(ngày) | 45 | 45 | 47 | 41 | 43 | 44 | 44 | 43 | 43 | 45 | 49 | 47 | |
GAAP Operating Expense Ratio (% of Operating Revenue)(%)1 | 11.4% | 11.1% | 12.8% | 11.0% | 10.5% | 10.1% | 10.9% | 10.7% | 11.8% | 11.7% | 11.6% | 11.8% | |
Adjusted Operating Expense Ratio (Non-GAAP — % of Operating Revenue)(%) | 11.3% | 11.0% | 10.5% | 10.8% | 10.4% | 10.0% | 10.7% | 10.3% | 9.4% | 11.4% | 11.3% | 11.6% | |
Consolidated GAAP Operating Margin (% of Operating Revenue)(%)2 | 2.5% | 3.5% | 4.2% | 0.6% | 2.6% | 4.9% | 6.5% | 1.5% | 3.1% | 6.4% | 7.1% | 3.0% | |
Consolidated Adjusted Operating Margin (Non-GAAP — % of Operating Revenue)(%) | 2.7% | 3.6% | 6.5% | 0.8% | 2.7% | 5.0% | 6.7% | 1.9% | 5.3% | 6.7% | 7.4% | 3.2% | |
GAAP Pretax Income Margin (% of Total Revenue)(%) | 3.5% | 3.8% | 4.6% | 0.4% | 2.8% | 4.6% | 5.7% | 1.3% | 3.0% | 6.8% | 6.9% | 2.3% | |
Gross Medical Claims Payable, Ending Balance($M)3 | 18,438 | 18,463 | 18,425 | 17,084 | 17,148 | 17,155 | 16,812 | 15,746 | 15,346 | 15,204 | 16,459 | 16,111 | |
Net Medical Claims Payable, Ending Balance($M) | 18,049 | 18,100 | 18,074 | 16,781 | 16,824 | 16,855 | 16,515 | 15,567 | 15,176 | 15,055 | 16,175 | 15,858 | |
Ceded Medical Claims Payable (Reinsurance Recoverable)($M) | 45 | 44 | 45 | 48 | 44 | 16 | 14 | 13 | 9 | 12 | 8 | 7 | |
Other Policyholder Liabilities & Future Policy Benefits($M) | 2,635 | 3,463 | 3,857 | 3,632 | 2,447 | 3,540 | 3,796 | 4,204 | 4,402 | 4,939 | 5,298 | 5,600 | |
Total Net Incurred Medical Claims($M)2 | 36,765 | 35,995 | 34,553 | 37,119 | 37,132 | 35,737 | 34,288 | 32,534 | 32,027 | 29,575 | 29,503 | 30,511 | |
Net Incurred Medical Claims — Current Incurred Year($M) | 36,865 | 36,066 | 35,677 | 37,143 | 37,333 | 35,777 | 35,313 | 32,655 | 32,164 | 29,843 | 30,708 | 30,740 | |
Net Incurred Medical Claims — Prior Years Redundancies (Favorable Reserve Development)($M) | -100 | -71 | -1,124 | -24 | -201 | -40 | -1,025 | -121 | -137 | -268 | -1,205 | -229 | |
Total Net Medical Claim Cash Payments($M)3 | 36,816 | 35,969 | 33,260 | 37,162 | 37,325 | 35,664 | 33,255 | 32,286 | 31,906 | 30,695 | 29,186 | 30,566 | |
Net Medical Claim Payments — Current Incurred Year($M) | 35,806 | 33,600 | 23,010 | 36,720 | 36,428 | 33,725 | 23,392 | 31,710 | 30,923 | 28,717 | 19,580 | 30,098 | |
Net Medical Claim Payments — Prior Incurred Years($M) | 1,010 | 2,369 | 10,250 | 442 | 897 | 1,939 | 9,863 | 576 | 983 | 1,978 | 9,606 | 468 | |
Medical Claims Payable Added via Business Combinations($M) | 0 | 0 | 0 | 0 | 162 | 267 | -85 | 143 | 0 | 0 | 0 | 0 | |
IBNR + Expected Development on Reported Claims — Current Claim Year($M)2 | 16,192 | 15,133 | 12,667 | 15,645 | 15,223 | 14,154 | 11,835 | 14,583 | 13,495 | 12,254 | 11,128 | 14,652 | |
IBNR + Expected Development on Reported Claims — Prior Claim Year (t-1)($M) | 1,445 | 2,419 | 4,653 | 829 | 1,258 | 2,247 | 3,979 | 792 | 1,396 | 2,349 | 4,323 | 843 | |
IBNR + Expected Development on Reported Claims — Older Claim Years (t-2 & Prior)($M) | 412 | 548 | 754 | 307 | 343 | 454 | 701 | 192 | 285 | 452 | 724 | 363 | |
Parent Company Cash and Investments (Quarterly 8-K Disclosure)($M) | 2,400 | 2,100 | 2,200 | 2,600 | 2,600 | 2,200 | 1,400 | 2,400 | 2,600 | 2,400 | 1,000 | 1,600 | |
Common Stock Repurchased and Retired — Total Cost($M)3 | 330 | 234 | 1,124 | 471 | 875 | 379 | 880 | 1,811 | 60 | 463 | 566 | 950 | |
Common Stock Repurchased — Quarterly Volume (8-K)(M) | 0.80 | 0.70 | 3.70 | 1.40 | 2.90 | 0.90 | 2.20 | 4.50 | 0.10 | 0.90 | 1.10 | 2 | |
Common Stock Repurchased — Weighted-Average Price per Share (8-K)($) | 399 | 345 | 305 | 336 | 303 | 410 | 396 | 401 | 511 | 525 | 493 | 466 | |
Board-Approved Share Repurchase Authorization Remaining($M) | 5,007 | 5,337 | 5,571 | 6,695 | 7,166 | 8,041 | 8,420 | 9,300 | 3,111 | 3,171 | 3,633 | 4,200 | |
AFS Fixed Maturity Securities — Total Fair Value($M)8 | 26,558 | 26,978 | 27,019 | 27,005 | 27,394 | 26,385 | 26,497 | 26,236 | 29,847 | 29,749 | 30,410 | 30,490 | |
AFS Fixed Maturity Securities — Amortized Cost($M) | 28,078 | 27,225 | 27,298 | 26,889 | 27,310 | 26,590 | 26,883 | 26,928 | 29,622 | 30,701 | 31,329 | 31,336 | |
AFS Fixed Maturity Securities — Gross Unrealized Gains($M) | 95 | 388 | 387 | 631 | 639 | 477 | 367 | 284 | 901 | 313 | 384 | 496 | |
AFS Fixed Maturity Securities — Gross Unrealized Losses($M) | 1,555 | 580 | 611 | 494 | 542 | 667 | 746 | 970 | 674 | 1,261 | 1,299 | 1,338 | |
AFS Fixed Maturity by Maturity — Due in 1 Year or Less (Fair Value)($M) | 289 | 272 | 200 | 238 | 279 | 294 | 196 | 196 | 259 | 197 | 365 | 470 | |
AFS Fixed Maturity by Maturity — Due in 1 to 5 Years (Fair Value)($M) | 3,167 | 3,581 | 3,848 | 4,305 | 4,890 | 4,712 | 4,647 | 4,772 | 5,117 | 5,376 | 5,900 | 7,193 | |
AFS Fixed Maturity by Maturity — Due in 5 to 10 Years (Fair Value)($M) | 8,972 | 9,273 | 9,400 | 10,697 | 10,580 | 10,454 | 10,578 | 10,378 | 11,627 | 11,055 | 10,864 | 10,325 | |
AFS Fixed Maturity by Maturity — Due After 10 Years (Fair Value)($M) | 5,979 | 5,785 | 5,473 | 6,585 | 6,408 | 5,878 | 5,785 | 6,090 | 7,106 | 7,369 | 7,460 | 6,624 | |
AFS Fixed Maturity by Maturity — Mortgage-Backed Securities (Fair Value)($M) | 8,151 | 8,067 | 8,098 | 5,180 | 5,237 | 5,047 | 5,291 | 4,800 | 5,738 | 5,752 | 5,821 | 5,878 | |
AFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value($M)2 | 2,772 | 3,326 | 3,656 | 4,208 | 4,757 | 5,321 | 5,971 | 6,649 | 8,118 | 10,919 | 12,097 | 14,842 | |
Unrealized Loss Position (≥ 12 Months) — Gross Unrealized Loss($M) | 542 | 428 | 441 | 423 | 410 | 539 | 620 | 752 | 656 | 1,123 | 1,199 | 1,283 | |
AFS Securities in Continuous Unrealized Loss Position (< 12 Months) — Fair Value($M)1 | 20,508 | 9,338 | 9,041 | 3,594 | 2,851 | 4,467 | 6,242 | 9,213 | 822 | 7,964 | 5,855 | 2,699 | |
Unrealized Loss Position (< 12 Months) — Gross Unrealized Loss($M) | 1,013 | 152 | 170 | 71 | 132 | 128 | 126 | 218 | 18 | 138 | 100 | 55 | |
Long-Term Other Invested Assets (Private Equity, Real Estate & Partnerships)($M)3 | 11,508 | 11,130 | 11,009 | 10,839 | 10,648 | 10,466 | 10,167 | 9,749 | 9,394 | 6,810 | 6,713 | 6,107 | |
Marketable Equity Securities — Fair Value($M) | 2,151 | 1,563 | 1,511 | 740 | 1,220 | 934 | 715 | 1,192 | 1,113 | 594 | 511 | 229 | |
Restricted Cash and Investments($M) | 500 | 668 | 527 | 348 | 397 | 519 | 695 | 409 | 339 | 400 | 499 | 294 | |
Accrued Investment Income Receivable($M) | 308 | 322 | 299 | 295 | 280 | 284 | 268 | 287 | 300 | 316 | 294 | 301 | |
Long-Term Debt, Less Current Portion — Carrying Value($M)2 | 30,382 | 30,669 | 30,768 | 30,797 | 31,173 | 28,178 | 28,110 | 29,218 | 24,688 | 24,561 | 21,976 | 23,246 | |
Long-Term Debt — Current Portion($M) | 375 | 375 | 350 | 1,099 | 749 | 1,648 | 1,643 | 1,649 | 2,100 | 2,900 | 2,900 | 1,649 | |
Short-Term Borrowings (FHLB Advances)($M) | 0 | 0 | 724 | 150 | 180 | 360 | 250 | 365 | 360 | 225 | 1,575 | 225 | |
Total Undiscounted Operating Lease Payments1 | |||||||||||||
Effective Income Tax Rate (%)(%) | 25.1% | 24.9% | 23.6% | 15.6% | 23.9% | 21.9% | 26.6% | 22.9% | 23.5% | ||||
Elevance Health (ELV) vs. Managed Care Peers — Total Consolidated Revenues($M)6 | 51,429 | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 | 45,106 | 43,886 | 42,577 | 42,647 | |
UnitedHealth Group (UNH) — Total Consolidated Revenues($M) | 112,032 | 111,721 | 113,215 | 113,161 | 111,616 | 109,575 | 100,807 | 100,820 | 98,855 | 99,796 | 94,427 | ||
CVS Health / Aetna (CVS) — Total Consolidated Revenues($M) | 106,096 | 100,426 | 105,693 | 102,871 | 98,915 | 94,588 | 97,710 | 95,428 | 91,234 | 88,437 | 93,813 | ||
The Cigna Group (CI) — Total Consolidated Revenues($M) | 71,668 | 68,494 | 72,472 | 69,748 | 67,178 | 65,502 | 65,649 | 63,694 | 60,523 | 57,255 | 51,114 | ||
Humana Inc. (HUM) — Total Consolidated Revenues($M) | 39,648 | 32,515 | 32,649 | 32,388 | 32,112 | 29,213 | 29,397 | 29,540 | 29,611 | 26,462 | |||
Centene Corporation (CNC) — Total Consolidated Revenues($M) | 50,647 | 53,579 | 49,944 | 49,725 | 49,690 | 48,742 | 46,620 | 40,805 | 42,023 | 39,836 | 40,407 | 39,460 | |
Molina Healthcare (MOH) — Total Consolidated Revenues($M) | 11,082 | 10,874 | 10,796 | 11,375 | 11,477 | 11,427 | 11,147 | 10,499 | 10,340 | 9,880 | 9,931 | 9,048 | |
Elevance Health (ELV) vs. Managed Care Peers — Insurance Premiums Revenue($M)5 | 41,704 | 41,279 | 41,024 | 40,690 | 41,791 | 41,271 | 40,887 | 36,245 | 36,809 | 35,416 | 35,696 | 35,138 | |
UnitedHealth Group (UNH) — Insurance Premiums Revenue($M) | 86,956 | 87,561 | 88,811 | 88,979 | 87,905 | 86,534 | 76,483 | 77,442 | 76,897 | 77,988 | 73,228 | ||
CVS Health / Aetna (CVS) — Insurance Premiums Revenue($M) | 35,117 | 33,791 | 34,017 | 33,719 | 34,195 | 32,820 | 30,913 | 30,925 | 30,667 | 30,391 | 25,075 | ||
The Cigna Group (CI) — Insurance Premiums Revenue($M) | 9,859 | 9,812 | 9,288 | 9,081 | 9,156 | 12,736 | 11,503 | 11,436 | 11,454 | 11,603 | 11,175 | ||
Humana Inc. (HUM) — Insurance Premiums Revenue($M) | 37,709 | 30,884 | 30,711 | 30,716 | 30,514 | 27,750 | 27,951 | 28,142 | 28,261 | 25,128 | |||
Molina Healthcare (MOH) — Insurance Premiums Revenue($M) | 10,457 | 10,244 | 10,172 | 10,715 | 10,841 | 10,868 | 10,628 | 9,983 | 9,694 | 9,446 | 9,504 | 8,362 | |
Elevance Health (ELV) vs. Managed Care Peers — Medical & Policyholder Benefits Expense($M)5 | 37,779 | 37,024 | 35,615 | 38,065 | 38,140 | 36,706 | 35,312 | 33,500 | 32,949 | 30,572 | 30,546 | 31,334 | |
UnitedHealth Group (UNH) — Medical & Policyholder Benefits Expense($M) | 75,358 | 73,489 | 82,041 | 79,958 | 78,585 | 73,411 | 67,035 | 65,957 | 65,458 | 65,735 | 62,231 | ||
CVS Health / Aetna (CVS) — Medical & Policyholder Benefits Expense($M) | 31,485 | 29,358 | 33,066 | 32,020 | 31,317 | 29,135 | 29,543 | 29,922 | 27,853 | 27,803 | 22,518 | ||
The Cigna Group (CI) — Medical & Policyholder Benefits Expense($M) | 8,430 | 7,924 | 8,260 | 7,842 | 7,749 | 10,498 | 10,166 | 9,527 | 9,515 | 9,440 | 9,280 | ||
Humana Inc. (HUM) — Medical & Policyholder Benefits Expense($M) | 33,707 | 28,721 | 27,991 | 27,565 | 26,535 | 25,381 | 25,120 | 25,039 | 25,124 | 22,782 | |||
Centene Corporation (CNC) — Medical & Policyholder Benefits Expense($M) | 41,128 | 39,029 | 38,303 | 41,489 | 40,902 | 38,808 | 36,503 | 31,809 | 32,201 | 30,765 | 30,932 | 30,634 | |
Elevance Health (ELV) vs. Managed Care Peers — Consolidated Operating Income (EBIT)($M)6 | 1,269 | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 | 1,408 | 2,765 | 3,016 | 1,284 | |
UnitedHealth Group (UNH) — Consolidated Operating Income (EBIT)($M) | 7,991 | 8,990 | 380 | 4,315 | 5,150 | 9,119 | 7,773 | 8,708 | 7,875 | 7,931 | 7,689 | ||
CVS Health / Aetna (CVS) — Consolidated Operating Income (EBIT)($M) | 4,703 | 4,680 | 2,112 | -3,207 | 2,381 | 3,374 | 2,368 | 832 | 3,045 | 2,271 | 3,373 | ||
The Cigna Group (CI) — Consolidated Operating Income (EBIT)($M) | 2,676 | 2,358 | 2,345 | 2,578 | 2,306 | 1,971 | 2,173 | 2,576 | 2,412 | 2,256 | 2,060 | ||
Humana Inc. (HUM) — Consolidated Operating Income (EBIT)($M) | 1,754 | -808 | 400 | 1,098 | 2,014 | -543 | 728 | 1,141 | 1,236 | -348 | |||
Centene Corporation (CNC) — Consolidated Operating Income (EBIT)($M) | -307 | 1,198 | 1,861 | -1,745 | -6,954 | -458 | 1,534 | 175 | 665 | 1,229 | 1,106 | -194 | |
Molina Healthcare (MOH) — Consolidated Operating Income (EBIT)($M) | 106 | 145 | 83 | -162 | 137 | 373 | 433 | 380 | 467 | 434 | 426 | 316 | |
Elevance Health (ELV) vs. Managed Care Peers — Medical Claims Payable Liability($M)5 | 18,438 | 18,463 | 18,425 | 17,084 | 17,148 | 17,155 | 16,812 | 15,746 | 15,346 | 15,204 | 16,459 | 16,111 | |
UnitedHealth Group (UNH) — Medical Claims Payable Liability($M) | 38,930 | 39,659 | 39,337 | 40,181 | 38,427 | 37,136 | 34,224 | 33,951 | 32,547 | 34,032 | 32,395 | ||
CVS Health / Aetna (CVS) — Medical Claims Payable Liability($M) | 16,203 | 15,404 | 15,329 | 15,300 | 14,296 | 14,565 | 14,984 | 14,521 | 13,850 | 14,387 | 12,067 | ||
Humana Inc. (HUM) — Medical Claims Payable Liability($M) | 12,691 | 9,967 | 10,088 | 11,060 | 11,451 | 10,440 | 11,125 | 11,446 | 11,729 | 10,241 | |||
Centene Corporation (CNC) — Medical Claims Payable Liability($M) | 21,495 | 20,262 | 20,627 | 20,544 | 21,493 | 20,117 | 19,911 | 18,308 | 17,995 | 18,173 | 18,109 | 18,000 | |
Molina Healthcare (MOH) — Medical Claims Payable Liability($M) | 4,988 | 4,841 | 4,941 | 4,887 | 4,844 | 4,885 | 4,804 | 4,640 | 4,732 | 4,577 | 4,571 | 4,204 | |
U.S. Personal Consumption Expenditures: Health Care Services (BEA / FRED) | 3,790.30 | 3,699.90 | 3,667.00 | 3,614.90 | 3,529.80 | 3,464.70 | 3,417.80 | 3,358.20 | 3,288.20 | 3,244.40 | 3,159.40 | ||
Total Consolidated Revenues (GAAP)($M)2 | 51,429 | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 | 45,106 | 43,886 | 42,577 | 42,647 | |
Consolidated Premiums Revenue($M) | 41,704 | 41,279 | 41,024 | 40,690 | 41,791 | 41,271 | 40,887 | 36,245 | 36,809 | 35,416 | 35,696 | 35,138 | |
Consolidated Net Investment Income($M) | 1,037 | 704 | 765 | 493 | 625 | 486 | 590 | 527 | 551 | 508 | 465 | 529 | |
Consolidated Operating Income (DB Standardized EBIT)($M)6 | 1,269 | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 | 1,408 | 2,765 | 3,016 | 1,284 | |
Consolidated Benefit Expense($M) | 37,779 | 37,024 | 35,615 | 38,065 | 38,140 | 36,706 | 35,312 | 33,500 | 32,949 | 30,572 | 30,546 | 31,334 | |
Consolidated Cost of Products Sold($M) | 5,640 | 5,492 | 5,463 | 5,522 | 5,380 | 5,293 | 4,983 | 6,012 | 5,093 | 4,820 | 3,825 | 4,837 | |
Consolidated Operating Expense (SG&A — GAAP)($M)1 | 5,752 | 5,547 | 6,330 | 5,415 | 5,272 | 4,997 | 5,300 | 4,804 | 5,269 | 5,066 | 4,886 | 4,999 | |
Adjusted Operating Expense (Non-GAAP)($M) | 5,684 | 5,492 | 5,212 | 5,349 | 5,223 | 4,934 | 5,215 | 4,636 | 4,218 | 4,930 | 4,776 | 4,925 | |
Consolidated Depreciation and Amortization($M) | 363 | 366 | 354 | 406 | 387 | 380 | 373 | 398 | 329 | 335 | 331 | 424 | |
Amortization of Other Intangible Assets($M) | 106 | 110 | 112 | 164 | 162 | 147 | 155 | 180 | 122 | 162 | 116 | 217 | |
Consolidated Interest Expense($M) | 358 | 364 | 357 | 366 | 351 | 341 | 344 | 340 | 300 | 280 | 265 | 259 | |
Shareholders' Net Income (GAAP)($M)3 | 1,365 | 1,463 | 1,764 | 547 | 1,189 | 1,743 | 2,183 | 418 | 1,016 | 2,300 | 2,246 | 856 | |
Adjusted Shareholders' Net Income (Non-GAAP)($M)1 | 1,520 | 1,624 | 2,772 | 739 | 1,349 | 1,997 | 2,719 | 747 | 2,005 | 2,405 | 2,537 | 1,325 | |
Non-GAAP Adj: Total Net Adjustment Items to Shareholders' Net Income($M)6 | 155 | 161 | 1,008 | 192 | 160 | 254 | 536 | 329 | 989 | 105 | 291 | 469 | |
Non-GAAP Adj: Amortization of Other Intangible Assets (Pre-Tax)($M) | 106 | 110 | 112 | 164 | 162 | 147 | 155 | 180 | 122 | 162 | 116 | 217 | |
Non-GAAP Adj: Net Losses (Gains) on Financial Instruments (Pre-Tax)($M) | 48 | 56 | 78 | 57 | 1 | 131 | 464 | 74 | 125 | 85 | 161 | 336 | |
Non-GAAP Adj: Transaction and Integration Related Costs (Pre-Tax)($M) | 42 | 44 | 47 | 54 | 49 | 53 | 80 | 66 | 42 | 64 | 52 | 59 | |
Non-GAAP Adj: Business Optimization Charges (Pre-Tax)($M) | -34 | -4 | 268 | 4 | -4 | 22 | |||||||
Non-GAAP Adj: Litigation and Settlement Expenses (Pre-Tax)($M) | 8 | 11 | 7 | 5 | 4 | 10 | 5 | 12 | 669 | 9 | 2 | -7 | |
Non-GAAP Adj: Income Tax Impact of Non-GAAP Adjustments($M) | -67 | -60 | -300 | -95 | -52 | -87 | -168 | -93 | -348 | -38 | -96 | -158 | |
Income Before Income Tax Expense (GAAP Pretax Income)($M) | 1,794 | 1,937 | 2,304 | 215 | 1,406 | 2,292 | 2,797 | 606 | 1,373 | 2,986 | 2,939 | 1,001 | |
Consolidated Income Tax Expense($M) | 451 | 483 | 544 | -331 | 219 | 548 | 613 | 193 | 365 | 685 | 690 | 170 | |
GAAP Diluted Earnings Per Share($)5 | 6.27 | 6.71 | 8 | 5.32 | 7.72 | 9.61 | 4.36 | 9.85 | 9.59 | ||||
Adjusted Shareholders' Diluted EPS (Non-GAAP)($) | 6.99 | 7.45 | 12.58 | 3.33 | 6.03 | 8.84 | 11.97 | 3.23 | 8.60 | 10.30 | 10.83 | 5.62 | |
GAAP Basic Earnings Per Share($) | 6.30 | 6.74 | 8.03 | 5.32 | 7.74 | 9.64 | 4.38 | 9.91 | 9.65 | ||||
Diluted Weighted-Average Common Shares(M) | 218 | 218 | 220 | -1 | 224 | 226 | 227 | -0.70 | 233 | 233 | 234 | -0.60 | |
Basic Weighted-Average Common Shares(M) | 217 | 217 | 220 | -1 | 223 | 225 | 226 | -0.60 | 232 | 232 | 233 | -0.50 | |
Common Stock Dividends Declared per Share($) | 1.72 | 1.72 | 1.72 | 1.71 | 1.71 | 1.71 | 1.71 | 1.63 | 1.63 | 1.63 | 1.63 | 1.48 | |
Total Consolidated Assets($M)6 | 127,801 | 126,438 | 125,827 | 121,494 | 122,749 | 121,938 | 119,717 | 116,889 | 116,533 | 112,988 | 111,894 | 108,928 | |
Cash and Cash Equivalents($M) | 10,348 | 10,232 | 9,657 | 9,491 | 8,713 | 8,560 | 7,500 | 8,288 | 7,866 | 6,497 | 6,226 | 6,526 | |
Premium Receivables, Net($M) | 10,686 | 10,991 | 11,525 | 10,073 | 9,535 | 10,465 | 10,359 | 8,011 | 7,209 | 8,040 | 8,931 | 7,902 | |
Premiums Receivable — Allowance for Credit Losses / Doubtful Accounts($M) | 180 | 187 | 205 | 167 | 168 | 163 | 178 | 183 | 185 | 177 | 212 | 212 | |
Other Receivables (Rebates, Pharmacy & Reinsurance)($M) | 7,610 | 6,818 | 6,167 | 6,307 | 7,692 | 7,206 | 6,576 | 6,016 | 6,055 | 5,881 | 5,120 | 5,405 | |
Property and Equipment, Net($M) | 4,613 | 4,645 | 4,657 | 4,679 | 4,657 | 4,641 | 4,617 | 4,652 | 4,505 | 4,450 | 4,451 | 4,359 | |
Goodwill($M) | 28,343 | 28,339 | 28,340 | 28,344 | 28,451 | 28,368 | 28,420 | 28,277 | 25,967 | 25,962 | 25,947 | 25,317 | |
Total Shareholders' Equity($M)4 | 44,681 | 44,883 | 43,902 | 43,882 | 43,953 | 43,722 | 42,503 | 41,315 | 43,775 | 42,191 | 40,608 | 39,306 | |
Total Consolidated Liabilities($M) | 83,007 | 81,416 | 81,785 | 77,468 | 78,667 | 78,087 | 77,097 | 75,463 | 72,654 | 70,691 | 71,184 | 69,523 | |
Unearned Income (Advance Premiums)($M) | 1,637 | 1,640 | 1,759 | 1,493 | 1,831 | 1,561 | 1,640 | 1,508 | 1,793 | 1,481 | 1,474 | 1,402 | |
Retained Earnings($M) | 37,368 | 36,675 | 35,796 | 35,393 | 35,586 | 35,549 | 34,546 | 33,549 | 35,157 | 34,575 | 33,088 | 31,749 | |
Accumulated Other Comprehensive Income (Loss)($M) | -1,676 | -711 | -741 | -451 | -543 | -760 | -911 | -1,147 | -489 | -1,387 | -1,365 | -1,313 | |
Net Cash Provided by Operating Activities (Operating Cash Flow)($M)4 | 1,267 | 1,913 | 4,332 | 84 | 1,135 | 2,054 | 1,017 | 706 | 2,677 | 447 | 1,978 | -2,971 | |
Operating Cash Flow as Multiple of GAAP Net Income(×) | 0.90 | ||||||||||||
Purchases of Property and Equipment (CapEx)($M) | 267 | 287 | 235 | 293 | 360 | 267 | 196 | 322 | 332 | 323 | 279 | 326 | |
Share-Based Compensation Expense($M) | 80 | 75 | 55 | 30 | 84 | 81 | 81 | -29 | 66 | 92 | 62 | 72 | |
Cash Dividends Paid to Common Shareholders($M) | 373 | 373 | 376 | 377 | 381 | 385 | 386 | 373 | 386 | 378 | 379 | 346 | |
8 chỉ số không có số liệu trong 12 quý gần nhất — .
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Fiscal calendar: Elevance Health, Inc. (formerly Anthem, Inc. prior to June 2022) operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q3 2026 (ended September 30, 2026, filed October 21, 2026 on Form 10-Q and Form 8-K) and Full-Year FY2025 (ended December 31, 2025, filed February 6, 2026 on Form 10-K).
- 2023 Segment Realignment: Effective Q1 2023, Elevance Health reorganized its reportable segments into Health Benefits (combining Commercial & Specialty Business and Government Business), CarelonRx (formerly IngenioRx), Carelon Services (health care services, behavioral health, complex & post-acute care), and Corporate & Other. Legacy segment series (Commercial & Specialty Business, Government Business) that ended in FY2022 are recorded in excluded metrics.
- 2024 Life & Disability Divestiture: On April 1, 2024, Elevance Health completed the sale of its Life and Disability business to StanCorp Financial Group (The Standard). Life and Disability membership (4,693 thousand members at Q1 2024) was discontinued beginning in Q2 2024 and is recorded in excluded metrics.
- Parent-Company Schedule II Evaluation (Step 3/4): Under 17 CFR § 210.5-04, Elevance Health includes Schedule II (Condensed Financial Information of Registrant — Parent Company Only) in Form 10-K because its state-regulated insurance and HMO subsidiaries are subject to statutory Risk-Based Capital (RBC) and dividend restrictions. Because the parent registrant is a pure holding company with no direct insurance underwriting revenue ($12M intercompany service fees vs. $197,584M consolidated operating revenue in FY2025), Consolidated − Parent subtraction is not applicable under Step 3(b); instead, Group 4 presents the exact published Schedule II Parent Company figures alongside Note 21 Statutory Capital & Surplus.
- CMS Medicaid Managed Care Enrollment (Group 6): Sourced directly from the official U.S. Centers for Medicare & Medicaid Services (CMS) Medicaid Managed Care Enrollment Reports (2016–2024). In 2024, Elevance Health rebranded several state Medicaid plans from Amerigroup to Wellpoint; state series continuously bridge Amerigroup (2016–2023) and Wellpoint (2024).
- Strict Step 4 & Step 5 Compliance: Every cell displays a point figure published by Elevance Health or official external sources (CMS, BLS/BEA via FRED, SEC XBRL peer filings), plus permitted period subtractions from cumulative disclosures (Q4 = FY − 9M and quarterly = YTD_t − YTD_{t-1}, marked with formula). Bound/approximate range statements from narrative commentary and guidance ('at least $22.00 GAAP EPS', 'at least $29.00 Adjusted EPS', 'at least $6.5 billion operating cash flow', 'over 104 million consumers served') are excluded from numeric cells.
Không hiện vì thiếu các kỳ gần đây (6)
- Other Membership — Life and Disability Members (discontinued in Q2 2024 following the April 1, 2024 divestiture of the Life and Disability business to StanCorp Financial Group; last reported 4,693 thousand members at Q1 2024)
- Medical Membership — Commercial & Specialty Business Subtotal & Government Business Subtotal (legacy segment structure replaced in Q1 2023 by Health Benefits)
- Medical Membership — Local Group, National Accounts, Self-Funded & Fully-Insured Breakdown (legacy customer/funding classification replaced in Q1 2021 by Commercial Risk-Based vs. Commercial Fee-Based)
- Reportable Segments (Legacy) — Commercial & Specialty Business, Government Business, IngenioRx & Other (realigned in Q1 2023 into Health Benefits, CarelonRx, Carelon Services, and Corporate & Other)
- Health Benefits & Carelon Segment Adjusted Operating Margin % (not reported in 2026 quarterly Form 8-K highlights; GAAP Segment Operating Margin % is reported continuously through Q3 2026)
- Narrative Bound / Outlook Range Figures — Full-Year 2026 GAAP EPS ('at least $22.00'), Adjusted EPS ('at least $29.00'), Operating Cash Flow ('at least $6.5 billion'), Total Enterprise Consumers Served ('over 104 million'), and Sydney Health Digital App Members ('over 22 million')
Dữ liệu cập nhật 2026-10-28.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
1. Medical Membership, Specialty Enrollment & Carelon Volume
2. Operating Segment Results & Disaggregated Revenue/Expense (Health Benefits, CarelonRx & Carelon Services)
3. Underwriting Performance, Medical Claims Payable Rollforward & Actuarial Assumptions (IBNR)
- Benefit Expense Ratio (BER / Medical Loss Ratio — % of Premiums) (%)40 kỳ
- Days in Claims Payable (DCP) (ngày)36 kỳ
- GAAP Operating Expense Ratio (% of Operating Revenue) (%)40 kỳ
- Consolidated GAAP Operating Margin (% of Operating Revenue) (%)40 kỳ
- Gross Medical Claims Payable, Ending Balance ($M)47 kỳ
- Total Net Incurred Medical Claims ($M)43 kỳ
- Total Net Medical Claim Cash Payments ($M)43 kỳ
- IBNR + Expected Development on Reported Claims — Current Claim Year ($M)15 kỳ
- Direct Insurance Premiums Earned (Before Reinsurance) ($M)12 kỳ
4. Insurance Subsidiary Statutory Capital & RBC, Parent Company Financial Statements (Schedule II), Share Repurchases & Headcount
- Statutory-Basis Capital & Surplus of Insurance/HMO Subsidiaries (Actual, excl. DMHC) ($M)9 kỳ
- California DMHC-Regulated Subsidiaries — Actual GAAP Equity ($M)9 kỳ
- Parent Company Cash and Investments (Quarterly 8-K Disclosure) ($M)35 kỳ
- Parent Company — Cash Dividends Received from Regulated Subsidiaries ($M)10 kỳ
- Parent Company Only (Schedule II) — Total Assets ($M)10 kỳ
- Parent Company Only (Schedule II) — Equity in Net Income of Subsidiaries ($M)11 kỳ
- Common Stock Repurchased and Retired — Total Cost ($M)43 kỳ
- Total Employees / Associates (Full-Time, Part-Time & Temporary)9 kỳ
- CEO Pay Ratio (CEO to Median Employee Total Compensation) (×)3 kỳ
5. Investment Portfolio (AFS Fixed Maturity & Alternatives), Intangible Asset Amortization, Operating Leases & Debt Maturity Schedule (XBRL Footnotes)
- AFS Fixed Maturity Securities — Total Fair Value ($M)18 kỳ
- AFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value ($M)13 kỳ
- Long-Term Other Invested Assets (Private Equity, Real Estate & Partnerships) ($M)47 kỳ
- Finite-Lived Intangible Assets, Net ($M)12 kỳ
- Long-Term Debt, Less Current Portion — Carrying Value ($M)47 kỳ
- Total Undiscounted Operating Lease Payments ($M)7 kỳ
6. State-by-State & National Medicaid Enrollment — U.S. Government Data (CMS Medicaid Managed Care Enrollment Report)
- U.S. National Total Medicaid Enrollment (CMS Managed Care Enrollment Report) (M)9 kỳ
- CMS Medicaid — North Carolina — Healthy Blue (Standard Plan Comprehensive MCO + MLTSS)4 kỳ
- CMS Medicaid — Texas — Wellpoint / Amerigroup Texas (STAR Comprehensive MCO)9 kỳ
- CMS Medicaid — Florida — Simply Healthcare Plans (Statewide Medicaid Managed Care MMA + LTSS)3 kỳ
- CMS Medicaid — Georgia — Amerigroup / Wellpoint Georgia Families (Comprehensive MCO)9 kỳ
- CMS Medicaid — Tennessee — Wellpoint / Amerigroup TennCare III (Comprehensive MCO + MLTSS)9 kỳ
- CMS Medicaid — Virginia — Anthem HealthKeepers Plus (Medallion 4.0 Comprehensive MCO)6 kỳ
- CMS Medicaid — Missouri — Healthy Blue (MO HealthNet Managed Care / 1915b)9 kỳ
- CMS Medicaid — Maryland — Wellpoint / Amerigroup Maryland HealthChoice9 kỳ
- CMS Medicaid — California — Anthem Blue Cross Partnership Plan (Two-Plan Model: Fresno / Kings / Madera)9 kỳ
- CMS Medicaid — Indiana — Anthem Blue Cross and Blue Shield (Healthy Indiana Plan — HIP)9 kỳ
- CMS Medicaid — California — Anthem Blue Cross Partnership Plan (Two-Plan Model: Santa Clara)9 kỳ
- CMS Medicaid — Indiana — Anthem Blue Cross and Blue Shield (Hoosier Healthwise — HHW)9 kỳ
- CMS Medicaid — Puerto Rico — MMM Healthcare / Triple-S (Plan Vital / Government Health Plan)5 kỳ
- CMS Medicaid — Louisiana — Healthy Blue (Healthy Louisiana Comprehensive MCO)7 kỳ
- CMS Medicaid — California — Anthem Blue Cross Partnership Plan (Geographic Managed Care: Sacramento)8 kỳ
- CMS Medicaid — Iowa — Wellpoint / Amerigroup Iowa (IA Health Link Comprehensive MCO + MLTSS)3 kỳ
- CMS Medicaid — Nevada — Anthem Blue Cross and Blue Shield Nevada Mandatory HMO7 kỳ
- CMS Medicaid — New Jersey — Wellpoint / Amerigroup New Jersey FamilyCare3 kỳ
- CMS Medicaid — Washington — Wellpoint / Amerigroup Washington Apple Health (FIMC)9 kỳ
- CMS Medicaid — Kentucky — Anthem Kentucky Managed Care Plan9 kỳ
- CMS Medicaid — South Carolina — Healthy Blue (BlueChoice HealthPlan Medicaid MCO)4 kỳ
- CMS Medicaid — California — Anthem Blue Cross Partnership Plan (Two-Plan Model: Tulare)9 kỳ
- CMS Medicaid — West Virginia — Wellpoint / UniCare Health Plan (Mountain Health Trust)9 kỳ
- CMS Medicaid — Wisconsin — Anthem Blue Cross and Blue Shield (BadgerCare Plus)9 kỳ
- CMS Medicaid — Texas — Wellpoint / Amerigroup Texas (STAR+PLUS ABD & MLTSS)9 kỳ
- CMS Medicaid — Virginia — Anthem HealthKeepers Plus (Commonwealth Coordinated Care Plus MLTSS)5 kỳ
- CMS Medicaid — District of Columbia — Wellpoint / Amerigroup DC Healthy Families4 kỳ
- CMS Medicaid — Puerto Rico — MMM Healthcare (Medicare Platino Dual-Eligible MCO)4 kỳ
- CMS Medicaid — Indiana — Anthem Blue Cross and Blue Shield (Hoosier Care Connect — Aged/Blind/Disabled)9 kỳ
- CMS Medicaid — Georgia — Amerigroup / Wellpoint Georgia Families 360° (Foster Care / Adoption)9 kỳ
- CMS Medicaid — Texas — Wellpoint / Amerigroup Texas (STAR Kids Children with Disabilities)8 kỳ
7. U.S. Health Insurance Peer Benchmarking (Big 7 Managed Care Peers XBRL) & Monthly Macroeconomic / Healthcare Inflation Indicators (FRED / BLS / BEA)
- Elevance Health (ELV) vs. Managed Care Peers — Total Consolidated Revenues ($M)43 kỳ
- Elevance Health (ELV) vs. Managed Care Peers — Insurance Premiums Revenue ($M)43 kỳ
- Elevance Health (ELV) vs. Managed Care Peers — Medical & Policyholder Benefits Expense ($M)43 kỳ
- Elevance Health (ELV) vs. Managed Care Peers — Consolidated Operating Income (EBIT) ($M)43 kỳ
- Elevance Health (ELV) vs. Managed Care Peers — Medical Claims Payable Liability ($M)43 kỳ
- U.S. Personal Consumption Expenditures: Health Care Services (BEA / FRED)42 kỳ
- Producer Price Index (PPI) — Direct Health & Medical Insurance Carriers (BLS PCU524114524114) (×)129 kỳ
- Consumer Price Index (CPI) — Medical Care in U.S. City Average (BLS CPIMEDSL) (×)128 kỳ
- U.S. Employment — Total Health Care Sector (BLS CES6562000101)129 kỳ
- U.S. Retail Sales — Pharmacies & Drug Stores (Census MRTSSM44611USS) ($M)128 kỳ
- U.S. Retail Sales — Health & Personal Care Stores (Census RSCCAS) ($M)129 kỳ
8. Consolidated Financial Statement Context & Non-GAAP Adjustments (Financial Statements + Q3 2026 Addition)
- Total Consolidated Revenues (GAAP) ($M)47 kỳ
- Consolidated Operating Income (DB Standardized EBIT) ($M)47 kỳ
- Shareholders' Net Income (GAAP) ($M)47 kỳ
- GAAP Diluted Earnings Per Share ($)42 kỳ
- Total Consolidated Assets ($M)47 kỳ
- Total Shareholders' Equity ($M)47 kỳ
- Net Cash Provided by Operating Activities (Operating Cash Flow) ($M)47 kỳ
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Elevance Health
- CMS Medicaid Managed Care Enrollment by Program and Plan (Table 4) ↗
- 8-K ER (FY2026Q3, 2026-10-21) ↗
- 10-K (FY2025, 2026-02-06) ↗
- 8-K ER (FY2025Q4, 2026-01-28) ↗
- Elevance Health (ELV) SEC 10-Q (XBRL) ↗
- 10-Q (2026-10-21) ↗
- Elevance Health (ELV) SEC 10-K (XBRL) ↗
- 8-K ER (FY2026Q1, 2026-04-22) ↗
- ELV 10-Q (XBRL us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense) ↗
- ELV 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtSecurities) ↗
- ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
- ELV 10-Q (XBRL us-gaap:OtherLongTermInvestments) ↗
See a number that looks wrong?